
New Insights into Niemann-Pick Disease, Type C: The Role of Genetic Testing
Explore Niemann-Pick Disease, Type C, its genetic origins, early diagnosis, and the pivotal role of genetic testing in treatment, family planning, and research.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore Niemann-Pick Disease, Type C, its genetic origins, early diagnosis, and the pivotal role of genetic testing in treatment, family planning, and research.

Explore how genetic testing in Non-Hodgkin Lymphoma aids in early detection, personalized treatment, and prognostic insights to enhance patient outcomes.

Unlock the potential of genetic testing in non-syndromic syndactyly with early diagnosis, personalized treatments, genetic counseling, and advancing research opportunities.

Unravel the complexities of non-syndromic X-linked intellectual disability through genetic testing. Discover insights into early diagnosis, family planning, and research.

Explore the impacts of genetic testing on diagnosing nonsyndromic hearing loss. Learn about gene mutations like MYO15A and their role in personalized treatment.

Explore how genetic testing confirms Noonan Syndrome diagnosis, guides treatment, and supports family planning. Learn the genetic basis and advancements in research.

Genetic testing confirms oculocutaneous albinism by identifying gene mutations, aiding diagnosis, early intervention, and informed family planning.

Explore how genetic testing aids in diagnosing Oguchi disease, a rare genetic disorder causing night blindness, improving diagnosis, family planning, and treatments.